PTCT
PTC Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$69.30
−2.94%Margins
Gross margin
82.1%
EBITDA margin
17.2%
EBIT margin
11.5%
Net margin
-3.8%
FCF margin
-33.0%
23.2%
Return on equity
-1.2%
Return on assets
21.9%
Return on invested capital
0.33x
Asset turnover
-$30.5M
Cash from operations
$27
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026